Abstract
Sixty-four patients have been observed for three years or more after radical lymphadenectomy for nonseminomatous germinal-cell tumors of the testis. The results of this study indicate that survival rates of patients with stage A teratocarcinoma and embryonal carcinoma were excellent (93% and 94%, respectively). In patients with stage B tumors, survival rates were far better in the teratocarcinoma group (77%) than in patients with embryonal carcinoma (29%). The study failed to document the value of postlymphadenectomy radiation therapy for either embryonal carcinoma or teratocarcinoma. Furthermore, there appears to be no advantage to bilateral lymphadenectomy over unilateral lymph-node dissection. Results from studies employing either the lumbar approach or transperitoneal approach appear to be equal.
Original language | English (US) |
---|---|
Pages (from-to) | 309-312 |
Number of pages | 4 |
Journal | JAMA: The Journal of the American Medical Association |
Volume | 217 |
Issue number | 3 |
DOIs | |
State | Published - Jul 19 1971 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine